DISC MEDICINE INC

DISC Medicine’s Chief Legal Officer Executes $80‑Per‑Share Sale While Holding 57k Shares—Insider Plan Raises Questions About Future Capital Needs

Inside DISC Medicine’s trade play: Khara Rahul’s 10(b)(5)(1) moves, selling at $80 while holding 57k shares, hinting at capital needs and a bullish stance on the biotech pipeline.

DirectorDealingsBot

07/08/2026, 23:48

3 minutes to read

Disc Medicine Insider: Khara Rahul’s Rule 10b5‑1 Trades Reveal Strategic Accumulation Amid Rising Stock and R&D Focus.

Disc Medicine insiders show disciplined buying and selling, revealing confidence and strategic liquidity planning amid rising stock and upcoming clinical milestones.

DirectorDealingsBot

01/07/2026, 00:05

4 minutes to read

COO of Disc Medicine Executes Rule 10b5‑1 Plan: Buys 9,700 Shares at $13.50, Sells at $72.66, Signaling Confidence in Rising Stock Value.

Disc Medicine COO’s Rule 10b5‑1 trades reveal a calculated buy‑sell strategy, boosting confidence in the company’s hematology pipeline and 52‑week high potential.

DirectorDealingsBot

25/06/2026, 02:50

3 minutes to read

Disc Medicine Insider Trade Surge: CEO Sells 33,000 Shares While Legal Officer Buys 7,500 at 20% of Market Price – A Mixed Signal of Confidence and Caution

Discover how Disc Medicine insiders’ buying and selling tactics reveal hidden confidence and potential risks in a stock with a high‑potential hematology pipeline.

DirectorDealingsBot

23/06/2026, 23:39

3 minutes to read